PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-10.22%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.18B
AUM Growth
+$3.18B
(-36%)
Cap. Flow
-$557M
Cap. Flow
% of AUM
-17.5%
Top 10 Holdings %
Top 10 Hldgs %
52.9%
Holding
144
New
7
Increased
15
Reduced
49
Closed
31
Top Buys
| 1 |
Amylyx Pharmaceuticals
AMLX
|
$39.8M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$39.6M |
| 3 |
Lyra Therapeutics
LYRA
|
$33.5M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$32.6M |
| 5 |
Eli Lilly
LLY
|
$32.4M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$143M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$52.5M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$34.5M |
| 4 |
Penumbra
PEN
|
$31.9M |
| 5 |
Travere Therapeutics
TVTX
|
$30.9M |
Sector Composition
| 1 | Healthcare | 84.05% |
| 2 | Consumer Discretionary | 0.04% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
